Foreword to the First Edition xiii Linus Pauling Introduction to the First Edition xv Elmer M. Cranton Introduction to the Second Edition xxi Elmer M. Cranton Section I: Scientific Rationale Scientific Rationale for EDTA Chelation Therapy in Treatment of Atherosclerosis and Diseases of Aging 3(59) Elmer M. Cranton James P. Frackelton Iron and Ischemic Heart Disease 62(5) Jerome L. Sullivan The Crosslinkage Theory of Aging As a Predictive Indicator 67(21) Johan Bjorksten Possibilities and Limitations of Chelation As a Means for Life Extension 88(12) Johan Bjorksten Nutritional Factors in Cardiovascular Disease 100(20) Alan R. Gaby Section II: Clinical Trials Current Status of EDTA Chelation Therapy in Occlusive Arterial Disease 120(13) Elmer M. Cranton James P. Frackelton EDTA Chelation Therapy: Efficacy in Arteriosclerotic Heart Disease 133(9) H. Richard Casdorph EDTA Chelation Therapy: Efficacy in Brain Disorders 142(22) H. Richard Casdorph An Oculocerebrovasculometric Analysis of the Improvement in Arterial Stenosis following EDTA Chelation Therapy 164(4) E. W. McDonagh C. J. Rudolph E. Cheraskin Effect of EDTA Chelation Therapy plus Multivitamin-Trace Mineral Supplementation upon Vascular Dynamics: Ankle/Brachial Doppler Systolic Blood Pressure Ratio 168(9) E. W. McDonagh C. J. Rudolph E. Cheraskin Effect of EDTA Chelation Therapy: Treatment of Peripheral Arterial Occlusion, an Alternative to Amputation 177(18) H. Richard Casdorph Charles H. Farr Ninety Percent Reduction in Cancer Mortality after Chelation Therapy with EDTA 195(7) Walter Blumer Elmer M. Cranton The ``Clinical Change'' in Patients Treated with EDTA Chelation plus Multivitamin/Trace Mineral Supplementation 202(8) Edward W. McDonagh Charles J. Rudolph E. Cheraskin EDTA Chelation Therapy: A Retrospective Study of 2,870 Patients 210(15) Efrain Olszewer James P. Carter Benefits of EDTA Chelation Therapy on Arteriosclerosis: A Retrospective Study of 470 Patients 225(12) C. Hancke K. Flythe Visual Field Evidence of Macular Degeneration Reversal Using a Combination of EDTA Chelation and Multiple Vitamin and Trace Mineral Therapy 237(10) C. J. Rudolph R.T. Samuels E. W. McDonagh A Nonsurgical Approach to Obstructive Carotid Stenosis Using EDTA Chelation 247(12) C. J. Rudolph E. W. McDonagh R.K. Barber The Effect of Intravenous Disodium Ethylenediaminetetraacetic Acid (EDTA) upon Bone Density Levels 259(6) C. J. Rudolph E. W. McDonagh D.G. Wussow Renal Artery Stenosis Reversal in a Hypertensive Individual, Using a Combination of EDTA Chelation and Multiple Vitamin and Trace Mineral Therapy 265(8) C. J. Rudolph E. W. McDonagh The Effect of EDTA Chelation Therapy with Multivitamin/Trace Mineral Supplementation upon Reported Fatigue 273(5) Edward W. McDonagh Charles J. Rudolph Emanuel Cheraskin Clinical Improvements as Judged by the Cornell Medical Index Questionnaire in Patients Treated with EDTA Chelation Therapy 278(7) Hugh D. Riordan Emanuel Cheraskin Marvin Dirks Farhad Tadayon Mavis Schultz Penny Brizendine A Pilot Double-Blind Study of Sodium-Magnesium EDTA in Peripheral Vascular Disease 285(9) Efrain Olszewer Fuad Calil Sabbag James P. Carter The Correlation between EDTA Chelation Therapy and Improvement in Cardiovascular Function: A Meta-Analysis 294(23) L. Terry Chappell John P. Stahl EDTA Chelation Treatment for Vascular Disease: A Meta-Analysis Using Unpublished Data 317(12) L. Terry Chappell John P. Stahl Ronald Evans If EDTA Chelation Therapy Is So Good, Why Is It Not More Widely Accepted? 329(16) James P. Carter Section III: Safety Kidney Effects of Ethylene Diamine Tetraacetic Acid (EDTA): A Literature Review 345(7) Elmer M. Cranton The Effect of EDTA Chelation Therapy plus Supportive Multivitamin-Trace Mineral Supplementation upon Renal Function: A Study in Serum Creatinine 352(9) E. W. McDonagh C. J. Rudolph E. Cheraskin The Improvement in Renal Function following EDTA Chelation and Multivitamin-Trace Mineral Therapy: A Study in Creatinine Clearance 361(5) Keith W. Sehnert A. F. Clague Emanuel Cheraskin The Effect of EDTA Chelation Therapy plus Supportive Multivitamin-Trace Mineral Supplementation upon Renal Function: A Study in Blood Urea Nitrogen (BUN) 366(10) E. W. McDonagh C. J. Rudolph E. Cheraskin Another Look at Renal Function and the EDTA Chelation Treatment Process 376(6) Hugh D. Riordan Emanuel Cheraskin Marvin Dirks Mavis Schultz Penny Brizendine Section IV: History and Protocol for Administration Overview, Historical Background, and Current Status of EDTA Chelation Therapy for Atherosclerosis 382(22) Michael B. Schachter Protocol for the Safe and Effective Administration of EDTA and Other Chelating Agents for Vascular and Degenerative Diseases 404(58) Theodore C. Rozema Iron and Copper Supplementation with EDTA Chelation Therapy 462(6) James P. Frackelton Elmer M. Cranton Section V: Laboratory Evaluation A Laboratory Method to Measure Plasma EDTA Levels 468(9) Zheng-Xian Liu Kim C. Harich Elmer M. Cranton Monitoring Renal Function during EDTA Chelation Therapy 477(7) James P. Frackelton Elmer M. Cranton Urinary Trace and Toxic Elements and Minerals in Untimed Urine Specimens Relative to Urine Creatinine, Part I: Concentrations of Elements in Fasting Urine 484(19) Elmer M. Cranton Zheng-Xian Liu Ivy M. Smith Urinary Trace and Toxic Elements and Minerals in Untimed Urine Specimens Relative to Urine Creatinine, Part II: Provoked Increase in Excretion following Intravenous EDTA 503(37) Elmer M. Cranton Zheng-Xian Liu Ivy M. Smith Testing for Toxic Elements and Chelation of Mercury 540(9) Elmer M. Cranton Index 549(16) About Dr. Cranton 565